Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Pregnancy outcomes in healthy nulliparas who developed hypertension

Go back to Resources

Pregnancy outcomes in healthy nulliparas who developed hypertension

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Overcoming recruitment roadblocks created by healthcare changes

Go back to Resources

Overcoming recruitment roadblocks created by healthcare changes

Authors:

Location:

Go back to Resources

Ocular surface inflammation in conjunctival biopsies of patients with moderate to severe keratodonjunctivitis sicca before and after treatment with Topical Cyclosporin A

Go back to Resources

Ocular surface inflammation in conjunctival biopsies of patients with moderate to severe keratodonjunctivitis sicca before and after treatment with Topical Cyclosporin A

Authors:

Location:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS) 10: Variability among academic glaucoma subspecialists in assessing optic disc notching

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS) 10: Variability among academic glaucoma subspecialists in assessing optic disc notching

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Tacrolimus vs. Cyclosporine as primary immunosuppression in pediatric renal transplant patients: a North American Pediatric Renal Cooperative Study (NAPRTCS) Report

Go back to Resources

Tacrolimus vs. Cyclosporine as primary immunosuppression in pediatric renal transplant patients: a North American Pediatric Renal Cooperative Study (NAPRTCS) Report

Authors:

Location:

Go back to Resources

Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) +/- antibody induction in simultaneous pancreas kidney (SPK) transplantation: one year results

Go back to Resources

Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) +/- antibody induction in simultaneous pancreas kidney (SPK) transplantation: one year results

Authors:

Location:

Go back to Resources

Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry

Go back to Resources

Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry

Go back to Resources

Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry

Authors:

Location:

Go back to Resources

Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes

Go back to Resources

Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Current page 133
  • Page 134
  • Page 135
  • Page 136
  • Page 137
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification